Clinical trial • Phase IV • Haematology

Clinical trial in Multiple myeloma

Phase IV trial for Multiple myeloma. None/Not specified-controlled. 50 participants.

Overview

Trial Therapeutic Area
Haematology
Trial Disease
Multiple myeloma
Trial Stage
Phase IV
Drug Modality
Cell therapy

Key dates

Initial CTIS Submission Date
05-06-2024
First CTIS Authorization Date
05-07-2024

Trial design

None/Not specified-controlled Phase IV trial across 13 sites in France.

Comparator
None/Not specified
Target Sample Size
50

Eligibility

Recruits 50 No vulnerable population selected (isVulnerablePopulationSelected=false). Consent/assent handling not specified..

Vulnerable Population
No vulnerable population selected (isVulnerablePopulationSelected=false). Consent/assent handling not specified.

Recruitment

Planned Sample Size
50
Recruitment Window Months
104
Consent Approach
Not specified in record.

Geography

Total Number Of Sites
13
Total Number Of Participants
50

France

Earliest CTIS Part Ii Submission Date
11-06-2024
Latest Decision Or Authorization Date
05-07-2024
Processing Time Days
24
Number Of Sites
13
Number Of Participants
50

Sites

Site Name
Centre Hospitalier Universitaire De Caen Normandie
Department Name
hematology
Contact Person Name
Margaret MACRO
Contact Person Email
macro-m@chu-caen.fr
Site Name
CHRU De Nancy
Department Name
hematology
Contact Person Name
Lauriane CLEMENT – FILIATRE
Contact Person Email
la.clement@chru-nancy.fr
Site Name
Centre Hospitalier Universitaire De Rennes
Department Name
hematology
Contact Person Name
Martine ESCOFFRE
Site Name
Centre Hospitalier Universitaire De Dijon
Department Name
hematology
Contact Person Name
Jean-Noel BASTIE
Contact Person Email
jean-noel.bastie@chu-dijon.fr
Site Name
Centre Hospitalier Universitaire De Lille
Department Name
hematology
Contact Person Name
Salomon MANIER
Contact Person Email
salomon.manier@chru-lille.fr
Site Name
Centre Hospitalier Universitaire De Bordeaux
Department Name
hematology
Contact Person Name
Cyrille HULIN
Contact Person Email
cyrille.hulin@chu-bordeaux.fr
Site Name
Centre Hospitalier Regional Universitaire De Tours
Department Name
hematology
Contact Person Name
Lofti BENBOUBKER
Contact Person Email
l.benboubker@chu-tours.fr
Site Name
Centre Hospitalier Departemental Vendee
Department Name
hematology
Contact Person Name
Mourad TIAB
Contact Person Email
mourad.tiab@chd-vendee.fr
Site Name
Centre Hospitalier Universitaire Grenoble Alpes
Department Name
hematology
Contact Person Name
Clara MARIETTE
Contact Person Email
cmariette@chu-grenoble.fr
Site Name
Hospices Civils De Lyon
Department Name
hematology
Contact Person Name
Lionel KARLIN
Contact Person Email
lionel.karlin@chu-lyon.fr
Site Name
Institut Universitaire Du Cancer Toulouse-Oncopole
Department Name
hematology
Contact Person Name
Aurore PERROT
Contact Person Email
perrot.aurore@iuct-oncopole.fr
Site Name
Centre Hospitalier Universitaire De Poitiers
Department Name
hematology
Contact Person Name
Xavier LELEU
Contact Person Email
xavier.leleu@chu-poitiers.fr
Site Name
Centre Hospitalier Universitaire De Nantes
Department Name
hematology
Contact Person Name
Philippe MOREAU
Contact Person Email
philippe.moreau@chu-nantes.fr

Sponsor

Primary sponsor

Full Name
Centre Hospitalier Universitaire De Nantes
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Investigational products

Combination Treatment
Yes

Related trials

Other published trials that may interest you.